Botulinum toxin treatment in cerebral palsy: Evidence for a new treatment option

J. Kirschner, S. Berweck, V. Mall, R. Korinthenberg, F. Heinen

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Intramuscular injections of botulinum toxin type A (BTX-A) have increasingly been used to reduce spasticity in specific muscle groups in children with cerebral palsy. Targets of therapeutic efforts are improvement of gross motor function, alleviation of pain or facilitation of hygienic care. Placebo-controlled studies have shown the local and functional effectiveness of BTX-A for the treatment of dynamic pes equinus. Whether long-term treatment with BTX-A improves motor development and delays contractures is still under investigation.

Original languageEnglish
Pages (from-to)I28-I30
JournalJournal of Neurology, Supplement
Volume248
Issue numberSUPPL. 1
DOIs
StatePublished - 2001
Externally publishedYes

Keywords

  • Botulinum toxin
  • Cerebral palsy
  • Children
  • Evidence
  • Pes equinus

Fingerprint

Dive into the research topics of 'Botulinum toxin treatment in cerebral palsy: Evidence for a new treatment option'. Together they form a unique fingerprint.

Cite this